Single-cell transcriptomic architecture and intercellular crosstalk of human intrahepatic cholangiocarcinoma
- PMID: 32505533
- DOI: 10.1016/j.jhep.2020.05.039
Single-cell transcriptomic architecture and intercellular crosstalk of human intrahepatic cholangiocarcinoma
Abstract
Background & aims: Intrahepatic cholangiocarcinoma (ICC) is the second most common liver malignancy. ICC typically features remarkable cellular heterogeneity and a dense stromal reaction. Therefore, a comprehensive understanding of cellular diversity and the interplay between malignant cells and niche cells is essential to elucidate the mechanisms driving ICC progression and to develop therapeutic approaches.
Methods: Herein, we performed single-cell RNA sequencing (scRNA-seq) analysis on unselected viable cells from 8 human ICCs and adjacent samples to elucidate the comprehensive transcriptomic landscape and intercellular communication network. Additionally, we applied a negative selection strategy to enrich fibroblast populations in 2 other ICC samples to investigate fibroblast diversity. The results of the analyses were validated using multiplex immunofluorescence staining, bulk transcriptomic datasets, and functional in vitro and in vivo experiments.
Results: We sequenced a total of 56,871 single cells derived from human ICC and adjacent tissues and identified diverse tumor, immune, and stromal cells. Malignant cells displayed a high degree of inter-tumor heterogeneity. Moreover, tumor-infiltrating CD4 regulatory T cells exhibited highly immunosuppressive characteristics. We identified 6 distinct fibroblast subsets, of which the majority were CD146-positive vascular cancer-associated fibroblasts (vCAFs), with highly expressed microvasculature signatures and high levels of interleukin (IL)-6. Functional assays indicated that IL-6 secreted by vCAFs induced significant epigenetic alterations in ICC cells, particularly upregulating enhancer of zeste homolog 2 (EZH2) and thereby enhancing malignancy. Furthermore, ICC cell-derived exosomal miR-9-5p elicited high expression of IL-6 in vCAFs to promote tumor progression.
Conclusions: Our single-cell transcriptomic dataset delineates the inter-tumor heterogeneity of human ICCs, underlining the importance of intercellular crosstalk between ICC cells and vCAFs, and revealing potential therapeutic targets.
Lay summary: Intrahepatic cholangiocarcinoma is an aggressive and chemoresistant malignancy. Better understanding the complex transcriptional architecture and intercellular crosstalk of these tumors will help in the development of more effective therapies. Herein, we have identified important interactions between cancer cells and cancer-associated fibroblasts in the tumor stroma, which could have therapeutic implications.
Keywords: CD146; Cancer-associated fibroblasts; Intrahepatic cholangiocarcinoma; Single-cell RNA sequencing; Tumor heterogeneity.
Copyright © 2020 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.
Conflict of interest statement
Conflict of interest The authors declare no conflicts of interest that pertain to this work. Please refer to the accompanying ICMJE disclosure forms for further details.
Comment in
-
Intrahepatic cholangiocarcinoma: A single-cell resolution unraveling the complexity of the tumor microenvironment.J Hepatol. 2020 Nov;73(5):1007-1009. doi: 10.1016/j.jhep.2020.07.017. Epub 2020 Sep 6. J Hepatol. 2020. PMID: 32900521 No abstract available.
Similar articles
-
Single-Cell Transcriptomic Analysis Reveals an Aggressive Basal-Like Tumor Cell Subpopulation Associated With Poor Prognosis in Intrahepatic Cholangiocarcinoma.J Gastroenterol Hepatol. 2025 May;40(5):1263-1273. doi: 10.1111/jgh.16915. Epub 2025 Feb 24. J Gastroenterol Hepatol. 2025. PMID: 39993788
-
Integrative analyses of bulk and single-cell transcriptomics reveals the infiltration and crosstalk of cancer-associated fibroblasts as a novel predictor for prognosis and microenvironment remodeling in intrahepatic cholangiocarcinoma.J Transl Med. 2024 May 3;22(1):422. doi: 10.1186/s12967-024-05238-z. J Transl Med. 2024. PMID: 38702814 Free PMC article.
-
Single-cell Transcriptomic Architecture Unraveling the Complexity of Tumor Heterogeneity in Distal Cholangiocarcinoma.Cell Mol Gastroenterol Hepatol. 2022;13(5):1592-1609.e9. doi: 10.1016/j.jcmgh.2022.02.014. Epub 2022 Feb 24. Cell Mol Gastroenterol Hepatol. 2022. PMID: 35219893 Free PMC article.
-
The immune milieu of cholangiocarcinoma: From molecular pathogenesis to precision medicine.J Autoimmun. 2019 Jun;100:17-26. doi: 10.1016/j.jaut.2019.03.007. Epub 2019 Mar 9. J Autoimmun. 2019. PMID: 30862450 Review.
-
Single-Cell RNA Sequencing in Lung Cancer: Revealing Phenotype Shaping of Stromal Cells in the Microenvironment.Front Immunol. 2022 Jan 19;12:802080. doi: 10.3389/fimmu.2021.802080. eCollection 2021. Front Immunol. 2022. PMID: 35126365 Free PMC article. Review.
Cited by
-
Omics-Based Platforms: Current Status and Potential Use for Cholangiocarcinoma.Biomolecules. 2020 Sep 28;10(10):1377. doi: 10.3390/biom10101377. Biomolecules. 2020. PMID: 32998289 Free PMC article. Review.
-
Single-cell transcriptome analysis of epithelial, immune, and stromal signatures and interactions in human ovarian cancer.Commun Biol. 2024 Jan 26;7(1):131. doi: 10.1038/s42003-024-05826-1. Commun Biol. 2024. PMID: 38278958 Free PMC article.
-
Single-cell dissection of cellular and molecular features underlying human cervical squamous cell carcinoma initiation and progression.Sci Adv. 2023 Jan 27;9(4):eadd8977. doi: 10.1126/sciadv.add8977. Epub 2023 Jan 27. Sci Adv. 2023. PMID: 36706185 Free PMC article.
-
Cancer-Associated Fibroblasts in Hepatocellular Carcinoma and Cholangiocarcinoma.Cell Mol Gastroenterol Hepatol. 2023;15(4):985-999. doi: 10.1016/j.jcmgh.2023.01.006. Epub 2023 Jan 25. Cell Mol Gastroenterol Hepatol. 2023. PMID: 36708970 Free PMC article. Review.
-
New molecular mechanisms in cholangiocarcinoma: signals triggering interleukin-6 production in tumor cells and KRAS co-opted epigenetic mediators driving metabolic reprogramming.J Exp Clin Cancer Res. 2022 May 26;41(1):183. doi: 10.1186/s13046-022-02386-2. J Exp Clin Cancer Res. 2022. PMID: 35619118 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials